Preventive maintenance services for its Bruker Preclinical BioSpec 3T MRI System and Bruker Avance Neo 700 nuclear magnetic resonance (NMR) spectrometer
Closed Special Notice Posted
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 811210 Electronic and Precision Equipment Repair and Maintenance
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Cancer Institute (NCI), under the Department of Health and Human Services, has published a Special Notice announcing its intent to award a sole source purchase order to Bruker Biospin Corporation for preventive maintenance services on specialized laboratory equipment. This notice, posted on February 19, 2026, with a response deadline of February 26, 2026, indicates that the government will solicit and negotiate directly with only one vendor rather than issuing a competitive solicitation. The procurement is being conducted under Federal Acquisition Regulation Subpart 13.106-1(b), which permits sole source acquisitions under specific circumstances. The contract will cover maintenance services for a Bruker Preclinical BioSpec 3T MRI System and a Bruker Avance Neo 700 nuclear magnetic resonance spectrometer located at NCI's Center for Clinical Cancer Metabolism.
The primary objective of this acquisition is to ensure the continued reliable operation of two critical research instruments through regularly scheduled preventive maintenance performed by the equipment manufacturer. The contractor must provide all labor, materials, and equipment necessary for preventive maintenance in accordance with the manufacturer's standard maintenance practices. The anticipated performance period extends from March 14, 2026 through March 13, 2028, if all options are exercised. This sole source procurement is classified under NAICS code 811210 (Electronic and Precision Equipment Repair and Maintenance) with a size standard of $34 million. Since this is a notice of intent to award rather than an open solicitation, interested parties beyond Bruker Biospin Corporation have limited opportunity to participate, and no competitive bids will be accepted.
Notice text
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE ORDER AND NOT A REQUEST FOR QUOTATIONS.
This contract action is for the acquisition of services for which the Government intends to solicit and negotiate with only one source under the authority of Federal Acquisition Regulation (FAR) Subpart 13.106-1(b). The National Cancer Institute (NCI) intends to award a single source purchase order to Bruker Biospin Corporation, 15 Fortune Drive, Billerica, MA 01821, for the acquisition of the preventive maintenance services for its Bruker Preclinical BioSpec 3T MRI System and Bruker Avance Neo 700 nuclear magnetic resonance (NMR) spectrometer.
The Center for Clinical Cancer Metabolism (CCM) has initiated several studies using a multinuclear magnetic resonance imaging (MRI) system, Bruker Preclinical BioSpec 3T. This MRI system is heavily used for various collaborative research projects on metabolic 13C labeled tracer MRI with a wide variety of branches within NCI and NIH; regular maintenance services are necessary for consistent performance of 13C MRI. The CCM utilizes the Bruker Avance Neo 700 nuclear magnetic resonance (NMR) spectrometer for clinical and research metabolomics applications. Periodic maintenance is required to ensure continued operation by keeping the instrument in good working order to avoid damage or failure.
The Contractor shall provide all labor, material and equipment for preventive maintenance on this machine. All maintenance services shall be performed in accordance with the manufacturer's standard maintenance practices.
The anticipated period of performance will be from March 14, 2026 through March 13, 2028, if all options are exercised.
The applicable North American Industry Classification System (NAICS) code for this acquisition is 811210 – Electronic and Precision Equipment Repair and Maintenance and a size standard of $34M.
NCI will solicit and negotiate directly with Bruker Biospin Corporation and no solicitation will be issued. Interested parties may identify their interest and capability. Award is subject to approval of the Sole Source Justification. This notice of intent is not a request for competitive proposals or quotations; however, an interested party may submit a statement of capabilities if they believe they can meet the above requirement. The statement of capabilities must be submitted in writing and contain sufficient detail to allow the Government to determine if the party can provide the requirement. A determination by the Government not to compete this proposed action based upon responses to this notice is solely with the discretion of the Government. All responses must be received within 10 days from the date of publication of this synopsis. Information received will normally be considered for the purpose of determining whether to conduct a competitive procurement. If no affirmative responses are received within 7 days of this notice, an award will be made to Bruker Biospin Corporation. This procurement is to be processed using Simplified Acquisition Procedures. There is no solicitation package available. For any questions regarding this announcement, please contact Elizabeth Bulger via email Elizabeth.bulger@hhs.gov.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity